Imbruvica 420 MG tablet 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FG2HG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,935
Award facts
- Contract value 100% obligated
- $31,934.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 mg tablets (28-count units) with a ceiling value of $31,934.72. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on December 16, 2025, with an ultimate completion date of January 8, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026, enabling comprehensive pharmaceutical supply across multiple therapeutic domains.
IMBRUVICA is a prescription medication used in oncology for treating certain blood cancers. This order represents one of numerous pharmaceutical deliveries AmerisourceBergen Drug Corp fulfills through its federal contract portfolio with the Defense Logistics Agency and related healthcare entities. The company's federal contracting history demonstrates extensive capability in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. The firm fixed-price structure and competitive award process underscore AmerisourceBergen Drug Corp's demonstrated ability to meet federal procurement requirements and supply critical medical products within established pricing parameters.
Quick answers
Who was awarded contract SPE2DR26FG2HG?
SPE2DR26FG2HG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FG2HG worth?
The government has obligated $31,935 on SPE2DR26FG2HG.
Is contract SPE2DR26FG2HG an order under another contract?
Yes. SPE2DR26FG2HG is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG2HG competed?
The extent of competition for SPE2DR26FG2HG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award